Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma
Hans C. Lee, Noopur Raje, Ola Landgren, Vijay Upreti, Jin Wang, Ariel A. Avilion, Xuguang Hu, Erik Rasmussen, Gataree Ngarmchamnanrith, Hisaki Fujii, Andrew Spencer
Topics & Concepts
Antibody-drug conjugateMultiple myelomaConjugateMedicineRefractory (planetary science)AntibodyDrugInternal medicineOncologyCancer researchPharmacologyImmunologyMonoclonal antibodyBiologyMathematicsAstrobiologyMathematical analysisMultiple Myeloma Research and TreatmentsHER2/EGFR in Cancer ResearchProtein Degradation and Inhibitors